The U.S. Market For Obesity Treatment & Weight Management

Published by: PJB Publications USA Inc.

Published: Jan. 1, 2001 - 214 Pages

Table of Contents

2. Introduction

2.1 Scope and Objectives of Report

2.2 Methodology

2.3 Importance of Obesity and Weight Loss Study

3. Overview of Obesity and Weight Loss Management

3.1 Description and Diagnosis

3.2 Etiology and Pathophysiology

3.3 Causes

3.4 Assessment

3.5 Costs

3.6 Health Risks

3.7 Weight Management

3.8 Prevalence, Incidence, Mortality

4. Trends in Obesity Treatment and Management

4.1 Education

4.2 Federal and Clinical Guidelines

4.3 Direct-to-Consumer Advertising

4.4 Regulatory Issues

4.5 Reimbursement Issues

4.6 Weight Loss Programs

4.7 Alternative Treatments

4.8 Discoveries

4.8.1 Obesity Virus

4.8.2 Fat Formation Molecular Switch

4.8.3 Cinnamon Extract

4.9 Diet Drug Shortage

4.10 Food Trends

5. Prescription Anti-obesity and Weight Loss Pharmaceutical Market

5.1 Treatment Option Overview

5.1.1 Potential Benefits of Medication Treatment

5.1.2 Potential Drawbacks of Medication Treatment

5.2 Appetite Suppressants

5.2.1 Adrenergic Agents

5.2.2 Serotonergic Agents

5.3 Lipase Inhibitors

5.4 Market Size and Growth

5.5 Competitive Analysis

6. Over-the-Counter Anti-obesity and Weight Loss Pharmaceutical Market

6.1 Appetite Suppressants

6.1.1 Noradrenergic Agents

6.1.2 Caffeine-Based Agents

6.1.3 Benzocaine-Based Agents

6.2 Fat Substitutes

6.3 Market Size and Growth

6.4 Competitive Analysis

7. Surgical Interventions

7.1 Description of Procedures

7.2 Procedure Volumes

7.3 Market Size and Growth

7.4 Market Analysis

8. Research and Development for Obesity and Weight Loss Management

8.1 Gene And Protein Discoveries

8.1.1 ACRP 30

8.1.2 ATP Binding Cassette-1

8.1.3 Agouti Related Protein

8.1.4 CAPN-10

8.1.5 CREB

8.1.6 DGAT

8.1.7 Fatty Acid Transport Protein 4

8.1.8 Follistatin

8.1.9 GATA

8.1.10 Genetically Engineered Antibodies

8.1.11 GNB3 825T

8.1.12 HMGIC

8.1.13 IRS-2

8.1.14 Mahogany Gene

8.1.15 Melanin-Concentrating Hormone

8.1.16 Melanin-Concentrating Hormone Receptor

8.1.17 Melanocortin-3 Receptor

8.1.18 Melanocortin-4 Receptor

8.1.19 Tubby Gene

8.1.20 Tyrosine Phosphatase

8.1.21 Uncoupling Protein Homologue

8.1.22 ZN-2-Glycoprotein

8.2 Pharmaceutical Research

8.2.1 Amylase Inhibitors

8.2.2 Aminosterol

8.2.3 â3-Receptor Agonists

8.2.4 Botanical

8.2.5 Bupropion

8.2.6 C75

8.2.7 CART Peptides

8.2.8 Cholecystokinin

8.2.9 Ciliary Neurotrophic Factor

8.2.10 Corticotropin-Releasing Factor

8.2.11 Desmethylsibutramine

8.2.12 Ecopipam

8.2.13 Galanin Agonist

8.2.14 Glucagon-Like Peptide I

8.2.15 H3 Histamine Antagonist

8.2.16 Human Growth Hormone Fragment

8.2.17 Human Steroidal Hormone

8.2.18 Intestinal Fat Absorber

8.2.19 Leptin

8.2.20 Leptin Promoters

8.2.21 Leptin Receptor

8.2.22 Lipase Inhibitors

8.2.23 Melanocortin

8.2.24 Melanin-Concentrating Hormone Receptor

8.2.25 Neuropeptide Y Inhibitors

8.2.26 Orlistat

8.2.27 Peroxisome Proliferation Activated Receptor-Gamma

8.2.28 RXR:PPARy BR>
8.2.29 R-Fluoxetine

8.2.30 Serotonin 2-C Receptor

8.2.31 Topiramate

8.3 Device Research

9. Total Market Size and Forecast

9.1 Market Size and Forecast

10. Company Profiles

10.1 Amgen, Inc.

10.2 Aventis Pharmaceuticals, Inc.

10.3 Celltech Group plc

10.4 Chattem, Inc.

10.5 Gate Pharmaceutical

10.6 Heritage Consumer Products, LLC

10.7 Knoll Pharmaceutical Co.

10.8 Novartis Pharmaceuticals Corp.

10.9 Pharmacia Corp.

10.10 The Procter & Gamble Company

10.11 Regeneron Pharmaceuticals, Inc.

10.12 Roche Laboratories, Inc.

10.13 Watson Pharmaceuticals, Inc.

11. Emerging Companies

11.1 Alizyme plc

11.2 Cyberonics, Inc.

11.3 Gliatech, Inc.

11.4 Ligand Pharmaceuticals, Inc.

11.5 Neurocrine Biosciences, Inc.

11.6 Neurogen Corp.

11.7 NeoTherapeutics, Inc.

11.8 Phytopharm Co.

11.9 Sepracor, Inc.

11.10 Trega Biosciences, Inc.

Appendix A: Selected Weight Loss Programs

Appendix B: Common Brand and Generic Products with Active Ingredient Phenylpropanolamine

Abstract

The U.S. Market for Obesity Treatment & Weight Management, a comprehensive sturdy from Theta Reports, thoroughly analyzes this growing market. You'll Learn About:

• The New drugs (both prescription and over-the-counter) in development.
• The other, non-pharmaceutical treatments (including surgical intervention) in development.
• The market share for these treatments.
• Who is developing these products, and what their market positions are.
• What other forces (reimbursement, government regulation) are affecting the market, and what their impact will be

The analyses and data in this report are gathered from interviews with company executives, company documents, and other primary sources. This report gives you the analysis and data you need to make the right strategic decisions to properly leverage the opportunities in this growing market.

Please Note: Theta requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.